Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Modifying the Oligo Backbone - Advice for PNA and UNA Chemistry

Published: Tuesday, December 10, 2013
Last Updated: Monday, December 09, 2013
Bookmark and Share
Link Technologies provides key protocols for oligonucleotide synthesis and modification.

Link Technologies Ltd is providing scientists with a complete resource for oligonucleotide synthesis and modification.

Spanning the breadth of oligo chemistry, the Link Technologies 2013/14 Product Guide leads users through practical methods and application-based advice for total assurance in reagent selection and performance of the resulting oligos.

Featuring specialist sections, including backbone modification strategies using Peptide Nucleic Acid (PNA) and Unlocked Nucleic Acid (UNA) reagents, the guide provides scientists with the information required to produce oligos that are suitable for both routine and highly specific application tasks. The resource is free to request as a hard copy or to download from www.linktech.co.uk.

Modification of the sugar-phosphate backbone with nucleic acid derivatives, including PNA and UNA, alters the structure and subsequent properties of the oligo. For antisense applications this is often favourable as PNA oligos, for example, display tighter binding to complementary DNA and RNA sequences, and with greater specificity.

In this way, PNA-modified oligos can provide a flexible tool for use in genetic diagnostics, and can also be applied more broadly to techniques such as in situ hybridization and PCR clamping. Contrastingly UNA modifications act to decrease the binding affinity with complementary strands, and so UNA incorporation has been exploited in siRNA-based silencing technology for example, to protect the siRNA from serum degradation without compromising potency.

For scientists looking to take advantage of these modified properties, the Link Technologies Product Guide collates referenced background information, established protocols and application notes, enabling the successful and confident synthesis of such oligos.

Featuring over 80 pages of protocols and quick-reference data summaries, the 2013/14 Product Guide has been produced by Link Technologies to provide invaluable technical and functional support for lab scientists using nucleic acid chemistry.

Amy Barker, Research Technician at the University of Leeds, explains: “My research group is concerned with developing RNA aptamers against various biological targets, and so in my role, keeping up to date with the latest advancements in nucleic acid modifications and reagents is vital. For me, the Link Technologies Product Guide is extremely useful - especially the protocols section - but the handy working examples and further external referencing are also an easy port-of-call when I’m required to synthesize new oligos.”


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More Than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

LINK Strengthens Presence in Japan with New Distribution Agreements
Link Technologies appoints Cosmo Bio and Shigematsu to work alongside Gene Design.
Tuesday, June 30, 2015
LINK Strengthens Board with Appointment of Marc Lemaître
Lemaître to join Link Technologies Ltd. as non-executive Director.
Wednesday, February 25, 2015
New SAB Supports LINK’s Growing Range of Innovative Reagents
LINK creates SAB with Brian Sproat and Thomas Rupp as first two appointments.
Friday, January 16, 2015
LINK Appoints New CEO
LINK has appointed Dr David Ricketts as its new Chief Executive Officer.
Tuesday, September 30, 2014
Shining the Light on Oligonucleotide Labelling
Link Technologies’ new Product Guide is the ‘go-to’ resource for oligo chemistry.
Tuesday, July 23, 2013
Link Technologies Announces Expansion into the Far East with New Distributor
Zirench Technology signed as local distributor for the Chinese market.
Thursday, June 13, 2013
Further Success for Link Technologies in Asia
Japanese company GeneDesign joins growing list of distributors.
Tuesday, February 26, 2013
Link Technologies Announces Partnership with American International Chemical
AIC to distribute Link’s specialist oligonucleotide modifiers in North America.
Wednesday, May 23, 2012
Link Technologies Secures Exclusive License for Ultra Sensitive Diagnostic Probes
Deal marks the start of ongoing collaboration between Link and The University of Manchester.
Tuesday, December 01, 2009
Link Technologies Inks Exclusive License to Agilent Technologies’ TC RNA Monomers
Under the terms of the agreement Link will manufacture and sell the four RNA monomer phosphoramidite reagents for use in research.
Monday, May 18, 2009
PNA Monomers: A Licence to Deal
Link Technologies to manufacture and sell PNA Monomers following deal with PNA Inventor Group.
Friday, June 22, 2007
Scientific News
The Changing Tides of the In Vitro Diagnostics Market
With the increasing focus in personalized medicine, diagnostics plays a crucial role in patient monitoring.
LaVision BioTec Reports on the Neuro Research on the Human Brain After Trauma
Company reports on the work of Dr Ali Ertürk from the Institute for Stroke and Dementia Research at LMU Munich.
NIH Study Shows No Benefit of Omega-3 Supplements for Cognitive Decline
Research was published in the Journal of the American Medical Association.
Less May Be More in Slowing Cholera Epidemics
Mathematical model shows more cases may be prevented and more lives saved when using one dose of cholera vaccine instead of recommended two doses.
Investigating the Vape
Expert independent review concludes that e-cigarettes have potential to help smokers quit.
NIH Launches Human RSV Study
Study aims to understand infection in healthy adults to aid development of RSV medicines, vaccines.
Researchers Discover Synthesis of a New Nanomaterial
Interdisciplinary team creates biocomposite for first time using physiological conditions.
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
Flu Remedies Help Combat E. coli Bacteria
Physiologists from the University of Zurich have now discovered why the intestinal bacterium Escherichia coli (E. coli) multiplies heavily and has an inflammatory effect.
Marijuana Genome Unraveled
A study by Canadian researchers is providing a clearer picture of the evolutionary history and genetic organization of cannabis, a step that could have agricultural, medical and legal implications for this valuable crop.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!